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Eg5, a mitotic kinesin exclusively involved in the forma-
tion and function of the mitotic spindle has attracted
interest as an anticancer drug target. Eg5 is co-crystal-
lized with several inhibitors bound to its allosteric bind-
ing pocket. Each of these occupies a pocket formed by
loop5/helix a2. Recently designed inhibitors additionally
o c c u p yah y d r o p h o b i cp o c k e to ft h i ss i t e .T h eg o a lo f
the present study was to identify new fragments which
fill this hydrophobic pocket and might be interesting
chemical moieties to design new inhibitors.
We’ve used the fragment based protocol of MED-
SuMo which exploits the whole PDB on the basis that
similar protein surfaces might bind the same fragment.
The MED-SuMo software is able to compare and super-
impose similar protein-ligand interaction surfaces at
PDB scale. Protein-fragment complexes are encoded as
MED-Portions by cross-mining 3D PDB ligand struc-
tures with fragment-like PubChem molecules. Inhibitors
a r ed e s i g n e db yh y b r i d i s i n gM E D - P o r t i o n sw i t hM E D -
Hybridise.
Without using the known Eg5 PDB ligands that
occupy the hydrophobic pocket, we’ve predicted new
potential ligands that would fill simultaneously both
pockets. Some of the latter are identified in libraries of
synthetically accessible molecules by the MED-Search
software.
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